Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: PharmaSwiss Česká republika s.r.o., Jankovcova 1569/2c, 170 00 Prague 7, Czech Republic
Emerade 150 micrograms solution for injection in pre-filled pen.
Emerade 300 micrograms solution for injection in pre-filled pen.
Emerade 500 micrograms solution for injection in pre-filled pen.
| Pharmaceutical Form |
|---|
|
Solution for injection in a pre-filled pen (auto-injector). Clear and colourless solution. |
The pre-filled pen contains 0.5 ml of adrenaline solution 1 mg/ml.
Emerade 150 micrograms delivers a single dose of 0.15 ml containing 150 micrograms of adrenaline (as tartrate).
Emerade 300 micrograms delivers a single dose of 0.3 ml containing 300 micrograms of adrenaline (as tartrate).
Emerade 500 micrograms delivers a single dose of 0.5 ml containing 500 micrograms of adrenaline (as tartrate).
Each 0.15 ml (150 micrograms) dose contains 0.075 mg sodium meta-bisulphite (E223).
Each 0.3 ml (300 micrograms) dose contains 0.15 mg sodium meta-bisulphite (E223).
Each 0.5 ml (500 micrograms) dose contains 0.25 mg sodium meta-bisulphite (E223).
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Epinephrine |
Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation. |
| List of Excipients |
|---|
|
Sodium chloride |
Emerade consists of a pre-filled syringe made of glass with a polyisoprene rubber needle plunger in an auto-injector. Emerade is latex free.
Emerade 150 micrograms: 16 mm
Emerade 300 micrograms and Emerade 500 micrograms: 23 mm
Emerade has an outer carton as well as a plastic box to store the auto-injector in.
Pack sizes: 1 or 2 pre-filled pens.
Not all pack sizes may be marketed.
PharmaSwiss Česká republika s.r.o., Jankovcova 1569/2c, 170 00 Prague 7, Czech Republic
Emerade 150 micrograms: PL 33616/0013
Emerade 300 micrograms: PL 33616/0014
Emerade 500 micrograms: PL 33616/0015
Date of first authorisation: 03 January 2013
| Drug | Countries | |
|---|---|---|
| EMERADE | Austria, Canada, Spain, Finland, France, Ireland, Netherlands, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
